MRP Capital Investments’s AbbVie ABBV Stock Holding History

MRP Capital Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$111K	Hold	512	–	–	0.1%	95
2025 Q4	$117K	Sell	512 -50	-9%	-$11.4K	0.1%	107
2025 Q3	$104K	Hold	562	–	–	0.09%	116
2025 Q2	$104K	Hold	562	–	–	0.07%	102
2025 Q1	$118K	Hold	562	–	–	0.11%	109
2024 Q4	$99.9K	Hold	562	–	–	0.09%	107
2024 Q3	$111K	Buy	+562	New	+$105K	0.11%	107
2023 Q3	–	Sell	-662	Closed	-$89.2K	–	93
2023 Q2	$89.2K	Hold	662	–	–	0.09%	131
2023 Q1	$106K	Sell	662 -1,905	-74%	-$291K	0.12%	105
2022 Q4	$415K	Buy	+2,567	New	+$394K	0.46%	61

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MRP Capital Investments's ABBV Position: Q1 2026 in Review

MRP Capital Investments held its AbbVie (ABBV) position steady in Q1 2026 at 512 shares worth $111K. The position accounts for 0.1% of the portfolio, ranked #95.

MRP Capital Investments first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. The position peaked at $415K in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

MRP Capital Investments held 512 shares of AbbVie worth $111K as of Q1 2026.
MRP Capital Investments left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.1% of MRP Capital Investments's portfolio in Q1 2026, its #95 holding.
MRP Capital Investments first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
MRP Capital Investments's AbbVie position peaked at $415K in Q4 2022.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MRP Capital Investments's 13F filing for Q1 2026, filed 14 May 2026.